Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E.
Other stock markets
 15:11:39 16/07/2024 BST 		5-day change 1st Jan Change
0.923 EUR +0.33% Intraday chart for Lavipharm S.A. +6.21% +15.95%
02-28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
LAVIPHARM S.A.
Generic Pharmaceuticals
+0.33%+6.21%+15.95%+34.94%-0.75% 169M
Bullish
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. Charts Lavipharm S.A.
  5. Comparison Chart